T1	Participants 88 115	patients with gastric ulcer
T2	Participants 151 185	Patients with benign gastric ulcer
T3	Participants 381 440	Fifty two patients entered the trial, and 12 were withdrawn
T4	Participants 1178 1190	peptic ulcer
